Pubblicazioni

Development of a combination strategy based on ER and oxidativa stress to target acute myeloid leukemia

2018 - HAEMATOLOGICAHAEMATOLOGICA

Masciarelli, Silvia; Capuano, E.; Ottone, T.; Divona, M.; Lavorgna, S.; Picardi, A.; Voso, M. T.; Lo-Coco, F.; Fazi, Francesco

RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF DYSFIBRINOGENEMIA AND HYPODYSFIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS

2017 - HAEMATOLOGICA

Santoro, Cristina; Massaro, Fulvio; Baldacci, Erminia; Ferrara, G.; Malaspina, Francesco; Santoro, Rc; Pasca, S.; Castaman, G.; Peyvandi, F.; Foa, Roberto; Mazzucconi, Maria Gabriella

VALIDATION OF THE REVISED IPSET-THROMBOSIS SCORE IN 734 PATIENTS WITH WHO 2016-DEFINED ESSENTIAL THROMBOCYTHEMIA. REPORT OF THE REGISTRO ITALIANO TROMBOCITEMIE

2017 - HAEMATOLOGICA

Gugliotta, L; Iurlo, A; Gugliotta, G; Tieghi, A; Gaidano, G; Dragani, A; Scalzulli, P; Martinelli, V; Martino, B; Randi, Ml; Appolloni, V; Maschio, N; Langella, M; Santoro, Cristina; Rago, A; Cacciola, E; Cacciola, R; Caocci, G; Plebani, S; Santoro, U; Vianelli, N; Mazzucconi, Maria Gabriella; Specchia, G.

RETROSPECTIVE EVALUATION OF PHENOTYPE AND MANAGEMENT OF A-HYPO-FIBRINOGENEMIA IN A COHORT OF ITALIAN PATIENTS

2017 - HAEMATOLOGICA

Santoro, Cristina; Massaro, Fulvio; Baldacci, E; Ferrara, G; Ferretti, Antonietta; Santoro, Rc; Pasca, S; Castaman, G; Peyvandi, F; Foa, Roberto; Mazzucconi, Maria Gabriella

IS THE SURVIVAL OF PATIENTS WITH ESSENTIAL THROMBOCYTEMIA BETTER IN THE LAST DECADE? RETROSPECTIVE ANALYSIS OF DATABASE OF LATIAL GROUP FOR THE STUDY OF NMP, PH NEGATIVE

2017 - HAEMATOLOGICA

Montanaro, M; Andriani, A; Cedrone, M; Santoro, Cristina; Spirito, F; Crescenzi, Sl; Porrini, R; Di Veroli, A; Villiva, N; Spadea, A; Rago, A; De Gregoris, C; De Muro, M; Felici, S; Breccia, M; Montefusco, E; Bagnato, A; Cimino, Giuseppe; Mazzucconi, Maria Gabriella; Latagliata, R.

PREDICTIVE FACTORS FOR INFECTIOUS ADVERSE EVENTS IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA TREATED WITH BENDAMUSTINE-RITUXIMAB (R)+/- R MAINTENANCE. RESULTS OF A RETROSPECTIVE ANALYSIS

2017 - HAEMATOLOGICA22nd Congress of the European-Hematology-Association

DI ROCCO, Alice; DE ANGELIS, Federico; Petrucci, L; Vozzella, F; De Benedittis, D; Foa, Roberto; Martelli, Maurizio

REGULATION OF BCR SIGNALLING IN CHRONIC LYMPHOCITYC LEUKEMIA: ROLE OF E3 UBIQUITIN LIGASE C-CBL

2017 - HAEMATOLOGICAREGULATION OF BCR SIGNALLING IN CHRONIC LYMPHOCITYC LEUKEMIA: ROLE OF E3 UBIQUITIN LIGASE C-CBL

Martini, V; Molfetta, R; Severin, F; Trimarco, V; Frezzato, F; Raggi, F; Martinello, L; Visentin, A; Scomazzon, E; Facco, M; Semenzato, G; Paolini, R; Trentin, L.

CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE CENTER ANALYSIS OF THE RISK FACTORS AND THE IMPACT OF CNS PROPHYLAXIS IN THE RITUXIMAB ERA

2016 - HAEMATOLOGICA21st Congress of the European-Hematology-Association

Ansuinelli, Michela; DI ROCCO, Alice; Fama, A; DE ANGELIS, Federico; Maiuri, Virginia; Minotti, C; Robin, F; Martelli, Maurizio

The pan-class I PI3 kinase inhibitor, NVP-BKM120, demonstrates anti-leukemic activity in acute myeloid leukemia

2015 - HAEMATOLOGICA

Allegretti, Matteo; Ricciardi, Maria Rosaria; Licchetta, Roberto; Mirabilii, Simone; Orecchioni, Stefania; Reggiani, Francesca; Talarico, Giovanna; Foa, Roberto; Bertolini, Francesco; Amadori, Sergio; Tafuri, Agostino

TPO-RECEPTOR AGONISTS AS TREATMENT PREPARING ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA TO SPLENECTOMY. RESULTS OF A RETROSPECTIVE, OBSERVATIONAL STUDY (GIMEMA ITP0614)

2015 - HAEMATOLOGICA

Zaja, F; Barcellini, W; Cantoni, S; Carpenedo, M; Caparrotti, G; Carrai, V; Di Renzo, N; Santoro, Cristina; Di Nicola, M; Veneri, D; Simonetti, F; Liberati, Am; Ferla, V; Paoloni, F; Crea, E; Tuniz, E; Fanin, R.

THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS AFFECTED BY PRIMARY IMMUNE THROMBOCYTOPENIA: ANALYSIS OF POSSIBLE PREDICTIVE FACTORS FOR SUSTAINED AND DURABLE RESPONSE FROM A RETROSPECTIVE CASE SERIES

2015 - HAEMATOLOGICA

Santoro, Cristina; De Angelis, F; Baldacci, Erminia; Abbruzzese, R; Barone, Francesco; Bochicchio, Ar; Chisini, Marta; Ferrara, G; Mattone, Pf; Volpicelli, P; Foa, Roberto; Mazzucconi, Maria Gabriella

ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA

2015 - HAEMATOLOGICA

Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Avvisati, G; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Ferrara, G; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, G; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella

SPLEEN ENLARGEMENT IS A RISK FACTOR FOR THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA: EVALUATION ON 1097 PATIENTS AND VALIDATION ON 792 PATIENTS

2015 - HAEMATOLOGICA

Andriani, A; Latagliata, R; Anaclerico, B; Spadea, A; Rago, A; Di Veroli, A; Spirito, F; Porrini, R; De Muro, M; Leonetti, Sc; Villiva, N; De Gregoris, C; Montefusco, E; Polverelli, N; Santoro, Cristina; Breccia, M; Cimino, Giuseppe; Majolino, I; Mazzucconi, Maria Gabriella; Vianelli, N; Alimena, G; Montanaro, M; Palandri, F.

OUTCOMES OF 65 PREGNANCIES IN 34 WOMEN WITH 5 DIFFERENT FORMS OF INHERITED PLATELET FUNCTION DISORDERS ENROLLED IN A RETROSPECTIVE AND MULTICENTRIC STUDY

2015 - HAEMATOLOGICA

Noris, P; Civaschi, E; Klersy, C; Melazzini, F; Pujol Moix, N; Santoro, Cristina; Cattaneo, M; Lavenu Bombled, C; Bury, L; Minuz, P; Nurden, P; Cid Haro, Ar; Cuker, A; Latger Cannard, V; Favier, R; Nichele, I; Balduini, Cl

BLEEDING RISK OF SURGERY IN PATIENTS WITH INHERITED PLATELET FUNCTION DISORDERS (IPFD): OUTCOME OF 389 SURGERIES IN 205 PATIENTS

2015 - HAEMATOLOGICA

Gresele, P; Noris, P; Orsini, S; Heller, P; Santoro, Cristina; Bury, L; Kadir, R; Mezzano, D; Falcinelli, E; Butta, N; Cid, Ar; Pozo, Jr; Miyazaki, K; Fabris, F; Fouassier, M; Flaujac, C; Ozdemir, Gn; Otomewo, O; Melazzini, F; Favier, R; Cattaneo, M; Bussel, J; De Maistre, E; Henskens, Y; De Candia, E; Bernejo, N; Schlegel, N.

HOW DIAGNOSTIC AND THERAPEUTIC APPROACHE CHANGED IN THE LAST DECADES IN THE PHILADELPHIA NEGATIVE MPN PATIENTS OF THE REGISTRO ITALIANO TROMBOCITEMIE (RIT)

2015 - HAEMATOLOGICA

Gugliotta, L; Iurio, A; Gugliotta, G; Tieghi, A; Candoni, A; Lunghi, M; Dragani, A; Antonioli, E; Scalzulli, Pr; Martinelli, V; Martino, B; Randi, Ml; Ricco, A; Appolloni, V; Maschio, N; Palmieri, R; Langella, M; Santoro, Cristina; Rago, A; Ragionieri, R; Codeluppi, K; Cacciola, E; Cacciola, R; Mastrullo, L; Esposito, Mr; Caocci, G; Lanza, F; Rupoli, S; Pierri, I; Porretto, F; Melpignano, A; Crugnola, M; Di Ianni, M; Plebani, S; Molinari, E; Spinosa, G; Santoro, M; Villani, O; Ricciotti, M; Musolino, C; Usala, E; Falzetti, F; De Biasi, E; Santoro, U; Federici, A; Vianelli, N; Mazzucconi, Maria Gabriella; Specchia, G.

ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA

2015 - HAEMATOLOGICA

Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Giuseppe, A; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, Giuliana; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella

HIGH DOSE SEQUENTIALCHEMOTHERAPY WITH RITUXIMAB AND ASCT AS FIRST LINE THERAPY IN ADULT MCL PATIENTS: CLINICAL AND MOLECULARRESPONSE OF THE MCL0208 TRIAL, A FIL STUDY

2015 - HAEMATOLOGICA20th Congress of European-Hematology-Association

Cortelazzo, S; Martelli, Maurizio; Ladetto, M; Ferrero, S; Ciccone, G; Evangelista, A; Mian, M; DI ROCCO, Alice; Chiappella, A; Rossi, G; Re, A; Zinzani, Pl; Balzarotti, M; Cavallo, F; Rusconi, C; Gotti, M; Arcaini, L; Gobbi, M; Gomes, M; Molinari, A; Liberati, Am; Michieli, M; Latte, G; Cabras, Mg; Novero, D; Paulli, M; Zamo, A; Chilosi, M; Federico, M; Vitolo, U.

THE IELSG-32 TRIAL: RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND HIGH-DOSE CYTARABINE WITH OR WITHOUT THIOTEPA, AND WITH OR WITHOUT RITUXIMAB, FOLLOWED BY BRAIN IRRADIATION VS HIGH-DOSE CHEMOTHERAPY SUPPORTED BY AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR IMMUNOCOMPETENT PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA

2015 - HAEMATOLOGICA45th Congress of the Italian-Society-of-Hematology

Ferreri, Ajm; Cwynarski, K; Pulczynski, E; Ponzoni, M; Politi, Ls; Ambrosetti, A; Vitolo, U; Ilariucci, F; Balzarotti, M; Fabbri, A; Tucci, A; Pisani, F; Levis, A; Cabras, Mg; D'Arco, M; Zaccaria, A; Angrilli, F; Guarini, Anna; Imola, M; Martelli, Maurizio; Cervetti, J; Zaja, F; Pinto, A; Liberati, M; Morra, E; Cortellazzo, Sf; Bassan, R; Foppoli, M; Citterio, G; Sassone, M; Scarfo, L; Cavalli, F; Finke, J; Reni, M; Zucca, E; Illerhaus, G.